EZH2 is a catalytic subunit that is part of the chromatin-modifying, epigenetic modulator polycomb repressor complex 2 (PRC2), and is overexpressed in PCa and associated with metastatic and neuroendocrine disease [223,224,225]. This evidence concerns the gene EZH2 and posterior cortical atrophy.